Cassava Sciences stock craters after Alzheimer’s drug trial flops in critical phase

Cassava Sciences, Inc., a clinical-stage biotechnology company, revealed a significant setback in its pursuit of an effective treatment for Alzheimer’s disease. The company reported that ... Read More